- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00655408
Iron-Deficiency Anemia in Infants in Two Weekly Programs (IDA)
Iron-Deficiency Anemia in Infants: Comparative Study of Two Weekly Supplement Programs
Study Overview
Detailed Description
Some studies have shown satisfactory results in reducing the prevalence of iron deficiency using weekly doses of ferrous sulfate, thereby avoiding these side effects. This deficiency is the most common nutritional disorder during childhood and does not only affect individuals from developing countries but also those from industrialized nations.
For infants with ages between six and 24 months, iron supplementation is the main treatment for iron deficiency. In this age range the prevalence of anemia is at least 20%. However, studies have shown a low rate of compliance by mothers during the recommended period, which may be caused by a lack of care or, more probably, due to the side effects caused by long-term daily ferrous sulfate supplementation, which include nausea, vomiting, diarrhea, staining of teeth and abdominal pain.
This specific study is randomized clinical trial study, achieved in a government healthcare clinic in Sao Jose do Rio Preto, Sao Paulo, Brazil. This study was carried out using two intervention groups. All children received 12 weekly doses of 25 mg of elemental iron, either administered in the government healthcare clinic or at the children's home.
The study showed treatment compliance in both groups. Prevalence of anemia for all children was 75% at the beginning of supplementation and 46.3% at the end of the period (p < 0.0005). Reduction rate for anemic children was 38.3%. Average increases in hemoglobin concentration levels were 0.75 g/dL and 0.65 g/dL, respectively, for home interventions and healthcare clinic administration (p < 0.00005).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages ranging between six and 24 months old
Exclusion Criteria:
- Positive results for the Guthrie test
- Use of ferrous sulfate supplements
- Infections process at the time of first consultation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A
For infants with ages between six and 24 months, iron supplementation is the main treatment for iron deficiency.This study was carried out using two intervention groups. All children received 12 weekly doses of 25 mg of elemental iron. Group 1 administered in the government healthcare clinic. Group 2 administered children's home. The study showed treatment compliance in both groups. |
Iron supplementation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Test (serum hemoglobin)
Time Frame: assessed at the before of the treatment period
|
assessed at the before of the treatment period
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Test (serum hemoglobin)
Time Frame: assessed after 12 weekly with iron supplement
|
assessed after 12 weekly with iron supplement
|
Collaborators and Investigators
Investigators
- Principal Investigator: Coutinho Geraldo Gaspar Paes Leme, MD, University Medical School f São Jose do Rio Preto-Brazil
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FAMERP-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Abdelwahed, Mai Mahmoud Mohamed, M.D.UnknownAnemia During PregnancyEgypt
-
University of California, DavisInstituto Mexicano del Seguro Social; Thrasher Research Fund; Mexican National... and other collaboratorsCompleted
-
Incyte CorporationActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Belgium, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom
-
Peking Union Medical College HospitalRecruiting
-
Alexion PharmaceuticalsWithdrawnWarm Autoimmune Hemolytic AnemiaUnited States
Clinical Trials on elemental iron
-
Assiut UniversityCompleted
-
George Washington UniversityColumbia University; Harvard School of Public Health (HSPH); Ifakara Health Institute and other collaboratorsNot yet recruiting
-
George Washington UniversityColumbia University; Harvard School of Public Health (HSPH); Ifakara Health Institute and other collaboratorsNot yet recruiting
-
University of Texas Southwestern Medical CenterGensavis Pharmaceuticals, LLCCompletedIron Deficiency AnemiaUnited States
-
Nadirah Rasyid RidhaHasanuddin UniversityCompletedIron Deficiency, Anaemia in ChildrenIndonesia
-
Liverpool University Hospitals NHS Foundation TrustRecruitingIron Deficiency Anemia | Inflammatory Bowel DiseaseUnited Kingdom
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); University of Ghana; Syracuse... and other collaboratorsRecruiting
-
All India Institute of Medical Sciences, New DelhiIndian Council of Medical ResearchCompleted
-
University of British ColumbiaUniversity of Guelph; NCHADS - Ministry of Health of CambodiaCompletedAnemia, Iron-Deficiency | Anemia | HemoglobinopathiesCambodia
-
George Washington UniversityColumbia University; Harvard School of Public Health (HSPH); Ifakara Health Institute and other collaboratorsNot yet recruiting